{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:17:57Z","timestamp":1760426277289,"version":"3.41.2"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pediatric cardiomyopathies are rare but life-threatening conditions with high mortality. Limited data exists on their clinical features and risk factors, especially in Asian populations, highlighting the need for further research in this area.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective cohort study analyzed data from 212 pediatric patients diagnosed with hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), or restrictive phenotype hypertrophic cardiomyopathy (RP-HCM) at a single center in China from October 2012 to October 2023, with follow-up until October 31, 2024. Demographic, clinical, and diagnostic data, as well as follow-up outcomes, were reviewed. Logistic and Cox regression models identified risk factors for in-hospital and long-term mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 212 patients, 79.72% (169\/212) had HCM, 16.98% (36\/212) had RCM, and 3.30% (7\/212) had RP-HCM. Infection (75.47%, 160\/212) and heart failure (51.42%, 109\/212) were common comorbidities. In-hospital mortality was 5.19% (11\/212), with follow-up mortality of 20.28% (43\/212). The independent risk factors for mortality included left ventricular ejection fraction (LVEF), pulmonary hypertension, and low-density lipoprotein (LDL) levels (<jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.05). Patients with RP-HCM showed the poorest outcomes, with a follow-up mortality rate of 42.86%. Only 10.4% (22\/212) of patients underwent genetic testing, yet the positive detection rate was 63.7% (14\/22).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study underscores the importance of early diagnosis, genetic testing, and integrated management in pediatric cardiomyopathies. LVEF, pulmonary hypertension, and LDL levels are critical prognostic factors, offering insights for risk assessment and management in affected children.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1541651","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:53:20Z","timestamp":1743400400000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics and mortality risk factors in pediatric hypertrophic, restrictive, and rapidly progressive hypertrophic cardiomyopathy: a retrospective cohort study with follow-up"],"prefix":"10.3389","volume":"12","author":[{"given":"Asad","family":"Nawaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixian","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Junaid","family":"Akram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIR.0000000000001151","article-title":"Treatment strategies for cardiomyopathy in children: a scientific statement from the American heart association","volume":"148","author":"Bogle","year":"2023","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000000682","article-title":"Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American heart association","volume":"140","author":"Lipshultz","year":"2019","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s00431-023-05358-6","article-title":"The clinical profile, genetic basis and survival of childhood cardiomyopathy: a single-center retrospective study","volume":"183","author":"Yuan","year":"2024","journal-title":"Eur J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"708732","DOI":"10.3389\/FPED.2021.708732","article-title":"Overview of cardiomyopathies in childhood","volume":"9","author":"Rath","year":"2021","journal-title":"Front Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7722","DOI":"10.3390\/ijms22147722","article-title":"Cardiomyopathies: an overview","volume":"22","author":"Ciarambino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/jcm11041104","article-title":"Left and right ventricular morphology, function and myocardial deformation in children with left ventricular non-compaction cardiomyopathy: a case-control cardiovascular magnetic resonance study","volume":"11","author":"Sarnecki","year":"2022","journal-title":"J Clin Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa021737","article-title":"The epidemiology of childhood cardiomyopathy in Australia","volume":"348","author":"Nugent","year":"2003","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/01.EPX.0000399140.68151.6a","article-title":"Pediatric cardiomyopathies over the last decade: a retrospective observational epidemiology study in a tertiary institute, Egypt","volume":"86","author":"Elmasry","year":"2011","journal-title":"J Egypt Public Health Assoc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/j.jacc.2007.02.061","article-title":"Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype","volume":"49","author":"Kubo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.euje.2007.06.008","article-title":"Incremental prognostic value of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler echocardiography study","volume":"9","author":"Pinamonti","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.amjcard.2009.07.057","article-title":"Prognostic implication of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy","volume":"104","author":"Biagini","year":"2009","journal-title":"Am J Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e002824","DOI":"10.1161\/CIRCGEN.119.002824","article-title":"Novel missense variant in MYL2 gene associated with hypertrophic cardiomyopathy showing high incidence of restrictive physiology","volume":"13","author":"De Bortoli","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e190158","DOI":"10.1148\/ryct.2020190158","article-title":"MRI characteristics, prevalence, and outcomes of hypertrophic cardiomyopathy with restrictive phenotype","volume":"2","author":"Li","year":"2020","journal-title":"Radiol Cardiothorac Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"suac011-047","DOI":"10.1093\/eurheartj\/suac011.047","article-title":"C48 prognostic impact of echocardiographic restrictive filling pattern in patients affected by hypertrophic cardiomyopathy and preserved systolic ejection fraction","volume":"24","author":"Priotto","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"B15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy-a heart failure society of America practice guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"key":"B16","doi-asserted-by":"publisher","first-page":"745365","DOI":"10.3389\/fped.2021.745365","article-title":"Pediatric restrictive cardiomyopathies","volume":"9","author":"Ditaranto","year":"2022","journal-title":"Front Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jjcc.2022.07.016","article-title":"Thirty-year outcome in children with hypertrophic cardiomyopathy based on the type","volume":"80","author":"Tsuda","year":"2022","journal-title":"J Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"101466","DOI":"10.1016\/j.eclinm.2022.101466","article-title":"Clinical characteristics and survival of children with hypertrophic cardiomyopathy in China: a multicentre retrospective cohort study","volume":"49","author":"Chan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e7886","DOI":"10.1097\/MD.0000000000007886","article-title":"Clinical features of idiopathic restrictive cardiomyopathy: a retrospective multicenter cohort study over 2 decades","volume":"96","author":"Hong","year":"2017","journal-title":"Medicine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.3390\/JCM10091954","article-title":"Hypertrophic cardiomyopathy and primary restrictive cardiomyopathy: similarities, differences and phenocopies.","volume":"10","author":"Vio","year":"2021","journal-title":"J Clin Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e017731","DOI":"10.1161\/JAHA.120.017731","article-title":"Genetic causes of cardiomyopathy in children: first results from the pediatric cardiomyopathy genes study","volume":"10","author":"Ware","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"suac121-409","DOI":"10.1093\/eurheartjsupp\/suac121.409","article-title":"263 Genetic causes of cardiomyopathies in children","volume":"24","author":"Girolami","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.3390\/jcm13092544","article-title":"Clinical genetic and genomic testing in congenital heart disease and cardiomyopathy","volume":"3","author":"Pidaparti","year":"2024","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3760\/cma.j.issn.0253-3758.2019.03.003","article-title":"Guideline for the genetic diagnosis of monogenic cardiovascular diseases","volume":"47","year":"2019","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"B25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/hrt.2006.095232","article-title":"Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study","volume":"93","author":"Nasermoaddeli","year":"2007","journal-title":"Heart"},{"key":"B26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.hrtlng.2021.11.006","article-title":"Factors associated with the risk of cardiac death in children with hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"52","author":"Xia","year":"2022","journal-title":"Heart Lung"},{"key":"B27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/eurjpc\/zwab181","article-title":"External validation of the HCM risk-kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy","volume":"29","author":"Norrish","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.amjcard.2018.01.045","article-title":"Idiopathic restrictive cardiomyopathy in children and young adults","volume":"121","author":"Anderson","year":"2018","journal-title":"Am J Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1161\/01.cir.101.21.2490","article-title":"Clinical profile and outcome of idiopathic restrictive cardiomyopathy","volume":"101","author":"Ammash","year":"2000","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5603\/CJ.a2015.0003","article-title":"Predictors of mortality in patients hospitalized for congestive heart failure with left ventricular ejection fraction \u2265 40","volume":"22","author":"Sherazi","year":"2015","journal-title":"Cardiol J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1164\/RCCM.202011-4183OC","article-title":"Mortality from pulmonary hypertension in the pediatric cardiac ICU","volume":"204","author":"Morell","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1527-5299.2007.07135.x","article-title":"Fish oil supplementation improves left ventricular function in children with idiopathic dilated cardiomyopathy","volume":"13","author":"Olgar","year":"2007","journal-title":"Congest Heart Fail"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e2422558","DOI":"10.1001\/jamanetworkopen.2024.22558","article-title":"Low-density lipoprotein cholesterol, cardiovascular disease risk, and mortality in China","volume":"7","author":"Chen","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1541651\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:53:23Z","timestamp":1743400403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1541651\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":33,"alternative-id":["10.3389\/fcvm.2025.1541651"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1541651","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"article-number":"1541651"}}